Misplaced Pages

This is an old revision of this page, as edited by BogBot (talk | contribs) at 18:23, 13 April 2012 (replaced secondary with primary DrugBank accession number per talk). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Hexylcaine" – news · newspapers · books · scholar · JSTOR (December 2009) (Learn how and when to remove this message)

Hexylcaine

Clinical data
ATC code	none
Pharmacokinetic data
Elimination half-life	<10 minutes
Identifiers
IUPAC name 1-cyclohexylaminopropan-2-yl benzoate
CAS Number	532-77-4
PubChem CID	10770
DrugBank	DB00473
ChemSpider	10315
UNII	511IU0826Z
KEGG	C14172
ChEMBL	ChEMBL1197
CompTox Dashboard (EPA)	DTXSID1047863
Chemical and physical data
Formula	C16H23NO2
Molar mass	261.359 g/mol g·mol
3D model (JSmol)	Interactive image
SMILES O=C(OC(CNC1CCCCC1)C)c2ccccc2
InChI InChI=1S/C16H23NO2/c1-13(12-17-15-10-6-3-7-11-15)19-16(18)14-8-4-2-5-9-14/h2,4-5,8-9,13,15,17H,3,6-7,10-12H2,1H3 Key:DKLKMKYDWHYZTD-UHFFFAOYSA-N
(verify)

Hexylcaine hydrochloride, also called cyclaine (Merck) or osmocaine, is a short-acting local anesthetic. It acts by inhibiting sodium channel conduction. Overdose can lead to headache, tinnitus, numbness and tingling around the mouth and tongue, convulsions, inability to breathe, and decreased heart function.

This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Drugs not assigned an ATC code
• Local anesthetics
• Benzoates
• Nervous system drug stubs